Ribonucleic Acid News and Research

RSS

Study evaluates hybridization probe capture for enriching coronavirus genomic material in bat oral and rectal swabs

Researchers surveilled coronaviruses found in bats via targeted genomic sequencing.

29 Apr 2022

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Researchers discussed the validity of the equation derived by Khoury et al. and reported by Muena et al. regarding the immunological correlate of protection to predict the efficacy of new coronavirus vaccines in a real-world setting.

29 Apr 2022

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Researchers examined the characteristics and outcomes of COVID-19 in immunocompromised patients.

29 Apr 2022

Artificial circular RNAs found to bypass cellular antiviral responses

Researchers produced artificial circular ribonucleic acid sponges in a permuted intron-exon system and showed that these did not activate innate immunity.

29 Apr 2022

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

In a new study, researchers described their self-designed chimeric receptor-binding domain-dimer vaccine approach to adapt SARS-CoV-2 variants of concern and variants of interest.

29 Apr 2022

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

In a recent study published in Biomedicines, researchers explored the utility of natural killer (NK) cells in coronavirus disease 2019 (COVID-19).

28 Apr 2022

Increased incidence of COVID-19 breakthrough cases associated with psychiatric disorders

Researchers investigated the relationship between past psychiatric disorder diagnoses and breakthrough cases of COVID-19 in fully vaccinated people.

27 Apr 2022

Google search data could predict new COVID-19 cases

Researchers showed that Google search data could be utilized for monitoring the spread of COVID-19 cases.

27 Apr 2022

Evaluating safety of three doses of messenger RNA-based COVID-19 vaccines

Researchers evaluated the safety profile and adverse events associated with COVID-19 boosters or additional vaccinations.

27 Apr 2022

Superior T-cell immunity in COVID vaccinated

A recent study published in the journal Public Library of Science (PLOS) ONE presented the T cell and humoral immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection against the SARS-CoV-2 original and mutant strains.

27 Apr 2022

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

A new study examined the protective effect of the mRNA booster vaccine against the SARS-CoV-2 Omicron variant in 21-month-old mice.

26 Apr 2022

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Researchers developed a highly pathogenic mouse-adapted SARS-CoV-2 strain to model mild, moderate, or COVID-19.

26 Apr 2022

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

The new study, published in the journal Vaccines, reports on an attempt to use the SARS-CoV-2 spike subunit protein to elicit an immune reaction.

26 Apr 2022

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

In a recent study published in the journal Nature, the researchers investigated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccine on memory B cells.

25 Apr 2022

Scientists show how T cells may help protect against severe COVID

In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related adaptive immunity.

25 Apr 2022

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant immune-mediated hepatitis.

25 Apr 2022

Vaccine effectiveness against COVID-19 infection and related hospitalization

Researchers assessed the effectiveness of COVID-19 vaccines against COVID-19 infections and related hospitalizations.

25 Apr 2022

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Researchers assessed factors influencing the anti-severe acute respiratory syndrome coronavirus 2 spike antibodies after SARS-CoV-2 BNT162b2 vaccination.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Ribonucleic Acid News and Research

Study evaluates hybridization probe capture for enriching coronavirus genomic material in bat oral and rectal swabs

Identifying the immunological correlate of protection to predict the efficacy of new coronavirus vaccines

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Artificial circular RNAs found to bypass cellular antiviral responses

Chimeric Delta-Omicron RBD-dimer vaccine found to be effective against SARS-CoV-2 variants

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Increased incidence of COVID-19 breakthrough cases associated with psychiatric disorders

Google search data could predict new COVID-19 cases

Evaluating safety of three doses of messenger RNA-based COVID-19 vaccines

Superior T-cell immunity in COVID vaccinated

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

Increased power and amplitude of memory B cells after SARS-CoV-2 mRNA booster

Scientists show how T cells may help protect against severe COVID

COVID-19 vaccine can elicit a distinct T cell-dominant immune-mediated hepatitis

Vaccine effectiveness against COVID-19 infection and related hospitalization

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The challenges of Omicron

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News